Personalised medicine specialist Lab21 has gained an exclusive global licence that allows the detection and analysis of genetic variants of the human carboxylesterase-1 gene (CES-1). Cambridge, UK-based Lab21 secured the right s from the Medical University of South Carolina’s ...
Please Login to read the full article.
